granocyte 34, 263 µg, suspension injectable, b/5fl+solv
sanofi-aventis france - lenograstime. - suspension injectable - 263 µg
lonquex
teva b.v. - lipegfilgrastim - neutropénie - les immunostimulants, , les facteurs de stimulation des colonies - lonquex is indicated in adults and in children 2 years of age and older for reduction in the duration of neutropenia and the incidence of febrile neutropenia in patients treated with cytotoxic chemotherapy for malignancy (with the exception of chronic myeloid leukaemia and myelodysplastic syndromes).
besponsa poudre pour solution
pfizer canada ulc - inotuzumab ozogamicine - poudre pour solution - 0.9mg - inotuzumab ozogamicine 0.9mg - antineoplastic agents
procytox tab 25mg comprimé
baxter corporation - cyclophosphamide - comprimé - 25mg - cyclophosphamide 25mg - antineoplastic agents
procytox tab 50mg comprimé
baxter corporation - cyclophosphamide - comprimé - 50mg - cyclophosphamide 50mg - antineoplastic agents
procytox poudre pour solution
baxter corporation - cyclophosphamide - poudre pour solution - 200mg - cyclophosphamide 200mg - antineoplastic agents
procytox poudre pour solution
baxter corporation - cyclophosphamide - poudre pour solution - 500mg - cyclophosphamide 500mg - antineoplastic agents
procytox poudre pour solution
baxter corporation - cyclophosphamide - poudre pour solution - 1000mg - cyclophosphamide 1000mg - antineoplastic agents
procytox poudre pour solution
baxter corporation - cyclophosphamide - poudre pour solution - 2000mg - cyclophosphamide 2000mg - antineoplastic agents
cyclophosphamide for injection poudre pour solution
accord healthcare inc - cyclophosphamide - poudre pour solution - 500mg - cyclophosphamide 500mg